Document is current
Any future updates will be listed below
-
Authors
Tunheim, Gro
Fossum, Even
Robertson, Anna Hayman
Rø, Gunnar Øyvind Isaksson
Chopra, Adity
Vaage, John T.
Vikse, Elisabeth Lea
Kran, Anne-Marte Bakken
Magnus, Per
Trogstad, Lill
Mjaaland, Siri
Hungnes, Olav
Lund-Johansen, Fridtjof
-
Funding
Funding for this research was provided by:
Norwegian Institute of Public Health
- License Information
-
More Information
Article History
Received: 10 October 2023
Accepted: 25 July 2024
First Online: 20 August 2024
Declarations
:
: This study was approved by the Regional Committee for Medical and Health Research Ethics in Southeastern Norway (REC) (reference number 157792 for use of the residual sera and reference number 18403 for the NorFlu cohort). For the residual sera, which were irreversibly anonymized before they were receive at the Norwegian Institute of Public Health, written informed consent is not required by Norwegian law and this has been specifically approved by REC. Written informed consent was obtained from all NorFlu cohort participants. For minors (NorFlu) written informed consent was obtained from both parents.The study was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
